Our RPA automations optimize the digital employee experience by handling tasks and sequences that do not require human intervention, freeing employees to focus on higher-value work .
Intelligent Automation
Advancing your automation journey
CGI helps clients use the full spectrum of automation—from robotic process automation (RPA) focused to artificial intelligence (AI) that ultimately will emulate full human cognition and empathy—wherever organizations are on their automation journey.
Primary tabs
CGI helps clients adopt emerging technologies, such as advanced analytics, artificial intelligence, RPA and Blockchain to drive new business models, services and products, reinvent customer touch points and address increasing cyber threats and regulatory demands.
As reflected in the CGI Client Global Insights, organizations have an accelerating need to become digital to meet customer expectations. As an essential enabler of digital transformation, automation technology is being used increasingly to:
-
Allow employees to focus on high-value work that optimizes the customer or citizen experience
-
Boost productivity, reduce costs, improve quality, increase security and enable real-time operations
-
When combined with advanced analytics, the Internet of things (IoT) and artificial intelligence (AI), enable entirely new business models
CGI helps clients identify and apply the right automation technologies to advance their digital agenda—from robotic process automation (RPA) to algorithmic automation to AI that ultimately will emulate full human cognition and empathy—no matter where organizations are on their automation journey.
Related media
Dear
Valued
Clients,
A
few
weeks
ago,
we
shared
a
message
about
our
commitment
to
provide
service
continuity
in
these
challenging
times.
Through
collaborating
with
you
and
your
teams,
...
As
the
COVID-19
pandemic
spread
across
the
globe
in
the
early
months
of
2020,
government
restrictions
on
work
and
travel
began
to
dramatically
impact
the
workforces
of
organizations,
large
and
...
Cardiovascular
disease
is
responsible
for
nearly
one-third
of
all
deaths
globally.
In
2018,
global
pharmaceutical
company,
MSD,
launched
“Innovating
Together”–a
contest
to
find
ways
to
combine
medicine
and
technology
to
...